As of 2024-12-12, the Intrinsic Value of Kura Oncology Inc (KURA) is
-12.70 USD. This KURA valuation is based on the model Peter Lynch Fair Value.
With the current market price of 10.20 USD, the upside of Kura Oncology Inc is
-224.54%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-12.70 USD
Intrinsic Value
KURA Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-12.70 - -12.70 |
-12.70 |
-224.54% |
| P/E |
(54.82) - (51.17) |
(58.56) |
-674.1% |
| DDM - Stable |
(17.95) - (47.17) |
(32.56) |
-419.2% |
| DDM - Multi |
(0.23) - (0.45) |
(0.30) |
-102.9% |
KURA Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
793.15 |
| Beta |
1.74 |
| Outstanding shares (mil) |
77.76 |
| Enterprise Value (mil) |
753.14 |
| Market risk premium |
4.60% |
| Cost of Equity |
11.38% |
| Cost of Debt |
5.00% |
| WACC |
11.29% |